“`html
Garrahan Hospital Leads Fight Against “Butterfly Skin” – Epidermolysis Bullosa
Table of Contents
A rare and debilitating genetic disorder, epidermolysis bullosa (EB), affects an estimated 1,200 people in Argentina, and Garrahan Hospital is at the forefront of diagnosis, treatment, and care for those living with this challenging condition.
The condition, often referred to as “butterfly skin” due to the extreme fragility of the skin, causes blisters to form with the slightest touch. The week of epidermolysis bullosa recently concluded, aiming to raise awareness of this often-invisible struggle.
Understanding Epidermolysis Bullosa
Congenital epidermolysis bullosa is characterized by a lack of proteins that bind skin layers together. This results in skin that blisters and tears easily, impacting not onyl the physical well-being of patients but also their quality of life. The severity of EB varies, with some forms affecting mucous membranes and leading to important complications.
According to a recent study presented at the World Congress of Pediatric Dermatology, the prevalence of EB in Argentina is estimated at 25.55 cases per million inhabitants. The condition typically manifests at birth or within the first few months of life.
Garrahan hospital: A Center of Excellence
For over two decades, Garrahan Hospital has been a leading center for the management of epidermolysis bullosa. The hospital’s multidisciplinary team (ETM), comprised of specialists in pediatrics, dermatology, nursing, gastroenterology, hematology, and numerous other fields, provides comprehensive care to between 50 and 70 patients annually.
“Accurate diagnosis is very relevant for clinical treatment, given the complexity and low prevalence of AD,” stated a coordinator of the ETM. The team emphasizes the critical role of molecular study in confirming a diagnosis,as clinical presentations can be arduous to differentiate.
The Importance of Genetic Diagnosis
The confirmatory diagnosis of EB relies on identifying mutations in the genes responsible for the condition. These studies are conducted at the Genodermatosis and Bullous Epidermolysis Research Center (CEDIGEA),affiliated with the University of Buenos Aires (UBA).
While there is currently no cure for epidermolysis bullosa, treatment focuses on wound management, preventing infections, and addressing associated complications. As one specialist explained, “Treatment is mainly aimed at the management and healing of wounds, prevention and treatment of associated complications.”
A Holistic Approach to Patient Care
The Garrahan Hospital team recognizes the profound impact EB has on patients and their families. Their approach extends beyond medical treatment to encompass psychological support, nutritional guidance, and social services.
skin infections represent the primary threat to patients with EB, highlighting the importance of meticulous wound care and preventative measures. Education is a cornerstone of this care, with healthcare professionals providing families with detailed instructions on wound healing, proper care techniques, and recognizing warning signs that necessitate immediate medical attention.
“Education is essential,so in each consultation doubts about wound healing are resolved,care guidelines are given,and the main alarm guidelines are explained to consult the nearest hospital early,” a hospital representative noted. This commitment to comprehensive care underscores Garrahan Hospital’s dedication to improving the lives of
